Thyroid disease and osteoporosis.
Prolonged elevation of thyroid hormones has been linked to osteoporosis and increased fracture risk. Whether thyroid hormone suppression also increases those risks remains controversial. Prophylaxis is often appropriate for patients who have had thyroid disorders, with assessment of bone mineral density and perhaps pharmacologic therapy for those with additional risk factors.
Burman
K D
KD
Washington Hospital Center, Washington, D.C., USA.
D015519:Bone Density; D002291:Carcinoma, Papillary / Q000188:drug therapy; D005260:Female; D006111:Graves Disease / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control; D012307:Risk Factors; D013959:Thyroid Diseases / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D013963:Thyroid Hormones / Q000378:metabolism / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000188:drug therapy; D016606:Thyroid Nodule / Q000188:drug therapy
D013963:Thyroid Hormones